Each injection plan is created just for you, so you get the best results
dialogue with other companies ongoing A new $299 savings offer, available from July 1 July 31, 2025, is designed to help new self-paying patients previously prescribed unapproved "semaglutide" start on FDA-approved Wegovy PLAINSBORO, N.J., June 26, 2025 /PRNewswire/ -- Novo Nordisk continues expansion of patient access to Wegovy (semaglutide) injection 2.4 mg through a new collaboration with WeightWatchers, a global leader in science-backed weight management, beginning July 1, 2025
For weight loss protocols requiring dose escalation, repeat this process for each dose level
If you do have a history of blood sugar issues or are on other medications that affect glucose levels, its important to talk with your provider so they can monitor your dose and symptoms closely